This is a working overview of 三重激动剂, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-25 and is reviewed periodically as new material appears.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Research-grade peptide material is commonly supplied as a lyophilized powder, a form that limits degradation during transport and storage. Standard practice keeps such material cold and protected from light and moisture, with tighter conditions used for long-term archives. Once dissolved, solutions are generally considered less stable than the dry powder and are handled on shorter timescales. These established conventions derive largely from general peptide chemistry rather than from compound-specific evidence alone.
Identification and purity assessment typically rely on reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Mass measurement confirms the expected molecular mass and can reveal truncations or modifications. Peptide mapping and sequencing techniques provide sequence-level confirmation when needed. Because related peptide impurities can behave similarly in a single method, orthogonal techniques are usually combined. Reported purity values depend heavily on the method used and should be interpreted with that in mind.
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
| Property | Value | Notes |
|---|---|---|
| Compound class | Synthetic triple-agonist peptide | Single linear chain carrying three receptor activities |
| Reported molecular weight | Approximately 4731 Da | Calculated from the published sequence; sources vary slightly |
| Appearance | White to off-white lyophilized powder | Typical of purified research-grade peptides |
| Solubility | Freely soluble in water; poorly soluble in nonpolar solvents | Dissolves in aqueous buffer near neutral pH |
| Storage of dry powder | -20 °C or below, desiccated, protected from light | Avoid repeated temperature cycling |
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。
retatrutide 是一种人工合成的多肽，设计目标是同时作用于 GIP、GLP-1 与胰高血糖素三种受体。这种三重激动设计试图把多条代谢通路的调节整合进单一分子，而不是只依赖一种肠促胰素受体。分子骨架以天然肽序列为基础，经过非天然氨基酸替换和脂肪酸侧链修饰，以获得更长的作用时间。该方向属于多受体激动剂研究的一部分，与双重激动剂的工作并行推进。
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Laboratories identify and quantify retatrutide using reversed-phase high-performance liquid chromatography coupled to mass spectrometry. This approach separates the peptide from related impurities and confirms identity through mass-to-charge measurements. Purity is commonly reported as the area percentage of the main peak relative to the total chromatogram. Ultraviolet detection near 214 nanometers is also used for peptide quantification, while intact mass analysis checks the molecular weight against a reference value.
As a peptide, the compound is generally supplied as a lyophilized powder and stored frozen to slow degradation. Recommended conditions usually sit at minus twenty degrees Celsius or colder, shielded from light and moisture. Solutions are less stable than the dry powder and are often prepared fresh before analysis. Repeated freeze-thaw cycles can drive aggregation, so splitting stock material into small aliquots reduces handling stress and preserves sample integrity.
Quality control of research material relies on several complementary checks. Purity testing confirms the absence of truncated or oxidized peptide species, while water content and counterion analysis show how much mass comes from salts rather than the peptide itself. Sequence verification through tandem mass spectrometry ensures the correct amino acid chain. Because unregulated suppliers vary widely, independent verification of identity and purity is often necessary before a sample enters experiments.
== External links == Gerritsen VB (September 2003). "The Plant Kingdom's sloth". Protein Spotlight. Swiss Institute of Bioinformatics (SIB). Rubisco plods along at a mere three molecules per second... To bypass such slothfulness, plants synthesize a gross amount of Rubisco, sometimes up to 50% of their total protein content!
The Sanger Institute About the 1958 Nobel Prize About the 1980 Nobel Prize Fred Sanger 2001 Video Documentary by The Vega Science Trust Portraits of Frederick Sanger at the National Portrait Gallery, London Frederick Sanger interviewed by Alan Macfarlane, 24 August 2007 (video), also available on Video on YouTube. Duration 57 minutes. Frederick Sanger archive collection – Wellcome Library finding aid for the digitised collection. Frederick Sanger on Nobelprize.org
The warfare grounded on certain uses of ICTs within an offensive or defensive military strategy endorsed by a state and aiming at the immediate disruption or control of the enemy's resources, and which is waged within the informational environment, with agents and targets ranging both on the physical and non-physical domains and whose level of violence may vary upon circumstances. Robinson et al. proposed in 2015 that the intent of the attacker dictates whether an attack is warfare or not, defining cyber warfare as "the use of cyber attacks with a warfare-like intent." In 2010, the former US National Coordinator for Security, Infrastructure Protection and Counter-terrorism, Richard A. Clarke, defined cyberwarfare as "actions by a nation-state to penetrate another nation's computers or networks for the purposes of causing damage or disruption". The target's own cyber-physical infrastructure may be used by the adversary in case of a cyber conflict, thus weaponizing it.
Sources: en.wikipedia.org
=== Parasitology === MALDI-TOF spectra have been used for the detection and identification of various parasites such as trypanosomatids, Leishmania and Plasmodium. In addition to these unicellular parasites, MALDI/TOF can be used for the identification of parasitic insects such as lice or cercariae, the free-swimming stage of trematodes.
All but two of Moore's cabinet nominees were unanimously confirmed by the Maryland Senate: Schiraldi, who faced opposition from Republicans over his policies toward juvenile justice reform; and Butler, whose critics claimed had not done enough to address complaints of racism and disparate treatment of Black officers in the Maryland State Police. Several of Moore's cabinet secretaries resigned in 2025. Kevin Anderson, the Maryland Secretary of Commerce, transitioned to an economic development advisor to the governor in January 2025 and was succeeded by Harry Coker, who served as the United States National Cyber Director from 2023 to 2025. Laura Herrera Scott resigned as Maryland Secretary of Health at the end of February 2025, and was succeeded by Meena Seshamani, who served as the director of the Centers for Medicare & Medicaid Services from 2021 to 2025. Anthony Woods resigned as Maryland Secretary of Veterans and Military Families to take a private sector job in May 2025, and was succeeded by Republican Carroll County commissioner Ed Rothstein in August 2025. In June 2025, Vincent Schiraldi resigned as Maryland Secretary of Juvenile Services, citing negative media attention of him and a small number of youth committing crimes, though Moore later claimed on WBAL-AM that he had "ordered" Schiraldi's resignation. In July 2025, Paul Wiedefeld said that he would resign as Maryland Secretary of Transportation on August 1; he was succeeded by Kathryn Thomas, who served as deputy administrator of the Federal Aviation Administration from 2023 to 2025.
== Scar free healing in nature == Unlike the limited regeneration seen in adult humans, many animal groups possess an ability to completely regenerate damaged tissue. Full limb regeneration is seen both in invertebrates (e.g. starfish and flatworms which can regenerate fully functioning appendages) and some vertebrates, however in the latter this is almost always confined to the immature members of the species: an example being tadpoles which can regrow their tails and various other body parts, an ability not seen in the mature frogs. The exception to this is the much studied urodele species' of amphibians, also known as salamanders, which carry their ability of complete regeneration into adulthood. These vertebrates possess an exceptional ability to allow regeneration of entire limbs and their tails (as well as a multitude of their internal organs as well, including their spinal cord) through a process known as blastema formation. This involves covering of the wound by a layer of epithelial cells known as the wound cap and subsequent innervation of this area with nerves that give off signals that revert local differentiated cells (such as muscle, cartilage and connective tissue) back to their undifferentiated cell lineage also known as mesenchymal cells. It is this area that is known as the blastema which has the potential to differentiate and proliferate once again allowing regrowth of the limb similar to how it occurs during development.
Sources: en.wikipedia.org
Clifford insisted that no British troops should be committed for the suppression of the rebellion. In October, Clarke arrived at Wepener at the head of a force of 1,000 cavalry, 600 infantry, five artillery pieces, and 40 wagons. Clarke was aiming to relieve Mafeteng, whose garrison was forced to exchange messages written in Greek, since some Basuto chiefs spoke both English and French. Clarke's advance was slowed by deep mud, and the Basuto cavalry regularly harried the column with rifle fire before withdrawing. On 19 October, the Cape army reached Qalabane, an isolated kop halfway between Wepener and Mafeteng. Lerotholi had positioned 3,000 of his warriors behind a ridge that overlooked a nearby road. The advanced guard of the Cape Mounted Yeomanry came under rifle fire from the kop. Clarke ordered the artillery to fire upon the kop and dispatched 200 men from the 1st Cape Mounted Yeomanry to flank the kop from the left. CMY commander Captain Dalgety ordered his soldiers to dismount and assume an open order formation. Chief Seiso's led a charge of 300 axe-wielding Basuto cavalrymen on Dalgety's unit before the latter was able to reach the crest. The 2nd CMY reinforced Dalgety soon afterwards and captured a nearby village. The Cape army lost 32 killed and seven injured, while the Basuto lost 40 killed. The yeomanry was almost defenseless in hand-to-hand combat, as it was not yet issued bayonets or swords.
Both hard-wired (cable) and through-water electronic voice communications systems may be used with surface-supplied diving. Wired systems are more popular as there is a physical connection to the diver for gas supply in any case, and adding a cable does not change the handling characteristics of the system. Wired communications systems are more reliable and simpler to maintain than through-water systems.
Though the push-pull technique was invented as a strategy to control stem-boring moths, such as Chilo partellus, through the manipulation of volatile host-finding cues, it was later discovered that allelopathic substances exuded by the roots of Desmodium spp. also contribute to the suppression of the damaging parasitic weed, Striga.
Sources: en.wikipedia.org
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.
No. As of the most recent public information it remains investigational in every jurisdiction. Material sold under this name outside trials is a research chemical, not an approved medicine. Current status should always be checked against regulator notices.
Dual agonists act on two receptors, usually GIP and GLP-1. Retatrutide adds glucagon receptor activity, which is associated with increased energy expenditure. Whether that third component adds clinically meaningful benefit over dual agonism remains an open question.
Mass spectrometry provides a mass value that can be compared with the expected value, while peptide mapping examines fragmentation patterns. Together these techniques support identity claims better than a single measurement can.